Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/17/1901   
Active ingredient: Itraconazole
Indication: Treatment of naevoid basal-cell carcinoma syndrome (Gorlin syndrome)
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/08/2017 Orphan designation EMA/OD/056/17 (2017)5910 of 23/08/2017
10/10/2017 Corrigendum (2017)5910 of 23/08/2017
28/02/2019 Transfer of orphan designation EMA/OD/0000004279 (2019)1744 of 26/02/2019